2019年全年我院销售金额前十药品点评报告分析

Analysis of the Top Ten Drug Review Reports of our Hospital in 2019

目的统计2019年销售前十药品处方,分析其临床使用所面临的问题,反映我院对药品使用的监管质量,为管控及合理用药提供保障。方法分析销售金额前十药品点评数据。结果各季度(Q)药品处方不合格的主要问题是处方不规范。与Q4相比,Q1、Q2和Q3的处方不规范存在明显差异(P<0.01,OR 3.35,95%CI:2.07~5.39;P<0.01,OR 3.82,95%CI:2.41~6.10;P<0.01,OR 5.14,95%CI:2.83~9.18)。结论2019年,我院处方不规范问题有所缓解,但仍需采用多方面的措施进行管理,提升药品临床使用合理性。

OBJECTIVE Through statistical analysis of the top ten drug prescription comment in 2019,this paper reflects the use of prescription drugs problems in hospital,and the supervision quality of prescription drugs use in our department,so as to provide guarantee for the control and rational use of such drugs.METHODS The results of top ten drug prescriptions in 2019 were collected and statistically analyzed.RESULTS The main problem of unqualified prescriptions of the top ten drugs sold in each quarter(Q)was that the prescriptions were not standardized.There were significant differences between Q1 and Q4,Q2 and Q4,Q3 and Q4 in the problem of nonstandard prescription(P<0.01,OR 3.35,95%CI:2.07-5.39;P<0.01,OR 3.82,95%CI:2.41-6.10;P<0.01,OR 5.14,95%CI:2.83-9.18).CONCLUSION In 2019,the problem of non-standard prescription in our hospital has been alleviated,but various measures still need to be taken for management to improve the rationality of clinical use of drugs.